GlassScriptPhysician profile
James O'Dowd
NPI 1093126336
$6,289.54
in general payments reported to CMS, 2019-2025
16 companies · $2,318 in 2025
The $2,318 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,109 · 2020: $992 · 2021: $258 · 2022: $190 · 2023: $331 · 2024: $1,091 · 2025: $2,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,718 · Travel and Lodging: $742 · Education: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,717.95 |
| Travel and Lodging | $742.35 |
| Education | $279.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $4,513.06 | 2019-2025 | Avenir, Persona, Rosa |
| Stryker Corporation | $708.08 | 2019-2025 | Profyle, Mako, Triathlon |
| Medical Device Business Services, INC. | $268.31 | 2019-2023 | |
| Smith+Nephew, INC. | $170.07 | 2019 | |
| Acumed LLC | $127.09 | 2019 | |
| Medtronic USA, INC. | $110.77 | 2019 | |
| Derma Sciences, INC. | $105.43 | 2019 | |
| Pacira Therapeutics, INC. | $100.36 | 2019 | |
| Integra Lifesciences Corporation | $58.73 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.33 | 2023 | Exparel, Zilretta |
| Bioventus LLC | $21.92 | 2019 | |
| Innovation Technologies INC | $21.50 | 2021 | |
| Orthalign INC | $21.19 | 2025 | Orthalign Plus |
| Sanofi-Aventis U.S. LLC | $21.02 | 2023 | |
| Checkpoint Surgical, INC | $18.68 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$31,002.16 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James O'Dowd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.